Results 111 to 120 of about 157,713 (224)

Outcomes in Children With Idiopathic Pulmonary Arterial Hypertension [PDF]

, 2004
Delphine Yung, Allison Widlitz, Erika B. Rosenzweig, Diane Kerstein, Greg Maislin, Robyn J. Barst   +5 more
openalex   +1 more source

Mitral valve transcatheter edge‐to‐edge repair in the elderly—A safe and effective therapy

ESC Heart Failure, EarlyView.
Mitral valve transcatheter edge‐to‐edge repair in elderly patients is safe and offers comparable mitral valve regurgitation reduction and symptom relief to younger patients. At 3 years, increased all‐cause mortality is observed in elderly patients with advanced heart failure and elevated EuroSCORE II.
Dominik Felbel, Michael Paukovitsch, Matthias Gröger, Sinisa Markovic, Leonhard Schneider, Wolfgang Rottbauer, Mirjam Keßler   +6 more
wiley   +1 more source

Effects of Adrenomedullin Inhalation on Hemodynamics and Exercise Capacity in Patients With Idiopathic Pulmonary Arterial Hypertension [PDF]

, 2004
Noritoshi Nagaya, Shingo Kyotani, Masaaki Uematsu, Kazuyuki Ueno, Hideo Oya, Norifumi Nakanishi, Mikiyasu Shirai, Hidezo Mori, Kunio Miyatake, Kenji Kangawa   +9 more
openalex   +1 more source

Inter‐atrial block as a predictor of adverse outcomes in patients with HFpEF

ESC Heart Failure, EarlyView.
Abstract Aims Inter‐atrial block (IAB), a marker of electrical atrial dysfunction, is associated with an increased risk of atrial fibrillation (AF) and adverse events in various populations. The prognostic impact of IAB in heart failure (HF) with preserved ejection fraction (HFpEF) remains unknown.
Jerremy Weerts, Sanne G.J. Mourmans, Helena Lopez‐Martinez, Mar Domingo, Arantxa Barandiarán Aizpurua, Michiel T.H.M. Henkens, Anouk Achten, Josep Lupón, Hans‐Peter Brunner‐La Rocca, Christian Knackstedt, Antoni Bayés‐Genís, Vanessa P.M. van Empel   +11 more
wiley   +1 more source

Microbiome-Immune Interaction in Pulmonary Arterial Hypertension: What Have We Missed? [PDF]

Research (Wash D C)
Zhou X, Tian W, Gu S, Rabinovitch M, Nicolls MR, Snyder MP.   +5 more
europepmc   +1 more source

The effect of trimetazidine on cardiac haemodynamics and mitochondrial function in wild‐type transthyretin amyloidosis

ESC Heart Failure, EarlyView.
Abstract Aims Wild‐type transthyretin cardiac amyloidosis (ATTRwt) is a cardiomyopathy causing myocardial hypoperfusion and impaired cardiac mitochondrial function. Trimetazidine is an antianginal agent used in patients with stable angina pectoris, which improves cardiac contractility and mitochondrial function.
Bertil Thyrsted Ladefoged, Anders Lehmann Dahl Pedersen, Anne Mette Dybro, Tor Skibsted Clemmensen, Julian Gillmore, Steen Hvitfeldt Poulsen   +5 more
wiley   +1 more source

The role of lactate metabolism and lactylation in pulmonary arterial hypertension. [PDF]

Respir Res
Peng TY, Lu JM, Zheng XL, Zeng C, He YH.
europepmc   +1 more source

Pathophysiological Insights from a Case of Reversible Pulmonary Arterial Hypertension

, 2003
D Mukerjee, Edward Kingdon, Mark Vanderpump, Gerry Coghlan   +3 more
openalex   +1 more source

The pathogenesis of pulmonary hypertension in hemodialysis patients via arterial-venous access [PDF]

, 2004
Farid Nakhoul
openalex   +1 more source

Up‐titration of medication in patients with new‐onset heart failure with and without atrial fibrillation

ESC Heart Failure, EarlyView.
Abstract Aims Differences in guideline‐directed medical therapy (GDMT) and clinical outcomes have been observed between heart failure (HF) patients with atrial fibrillation (AF) versus those in sinus rhythm. This study evaluated the effects of up‐titration of HF therapies, consisting of beta‐blockers, angiotensin‐converting‐enzyme inhibitors (ACEis ...
Arietje J.L. Zandijk, Bernadet T. Santema, Friso D.J. Inkelaar, Martje H.L. van der Wal, Janke Warink‐Riemersma, Michiel Rienstra, Adriaan A. Voors   +6 more
wiley   +1 more source